S 2440
115th Congress
Senate
Crime and Law Enforcement
Administrative law and regulatory procedures
Business records
Civil actions and liability
Department of Justice
Drug Enforcement Administration (DEA)
Drug trafficking and controlled substances
Executive agency funding and structure
Government information and archives
Marketing and advertising
Prescription drugs
Television and film
CARES Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 15, 2018
Read twice and referred to the Committee on the Judiciary.
Feb 15, 2018
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Comprehensive Addiction Reform, Education, and Safety Act of 2018 or the CARES Act
This bill establishes new requirements related to the marketing and distribution of controlled substances.
Among other things, the bill does the following:
- requires predissemination review of television advertisements for controlled substances,
- increases penalties for drug manufacturers who commit certain violations involving opioids, and
- requires the prior conviction records of opioid manufacturers to be made publicly available.
What's happening now
Read twice and referred to the Committee on the Judiciary.
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 2440: CARES Act. 115th Congress. Open America. https://openamerica.io/bill/115-S-2440/
"S. 2440: CARES Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2440/.
S. 2440, 115th Cong. (2026), https://openamerica.io/bill/115-S-2440/.
[S. 2440: CARES Act](https://openamerica.io/bill/115-S-2440/)